CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 21 filers reported holding CANDEL THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,931,348 | +6622.0% | 472,798 | +1613.0% | 0.00% | – |
| Q1 2024 | $43,608 | +7.5% | 27,600 | 0.0% | 0.00% | – |
| Q4 2023 | $40,572 | +58.1% | 27,600 | 0.0% | 0.00% | – |
| Q3 2023 | $25,668 | -26.2% | 27,600 | 0.0% | 0.00% | – |
| Q2 2023 | $34,776 | -8.0% | 27,600 | 0.0% | 0.00% | – |
| Q1 2023 | $37,812 | -61.7% | 27,600 | -50.0% | 0.00% | – |
| Q4 2022 | $98,808 | +13.6% | 55,200 | +100.0% | 0.00% | – |
| Q3 2022 | $87,000 | -2.2% | 27,600 | 0.0% | 0.00% | – |
| Q2 2022 | $89,000 | -36.4% | 27,600 | 0.0% | 0.00% | – |
| Q1 2022 | $140,000 | -32.7% | 27,600 | +3.8% | 0.00% | – |
| Q4 2021 | $208,000 | -27.8% | 26,600 | 0.0% | 0.00% | – |
| Q3 2021 | $288,000 | – | 26,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 1,935,215 | $11,998,333 | 21.71% |
| Sands Capital Ventures, LLC | 405,837 | $2,516,189 | 0.84% |
| Alpine Global Management, LLC | 18,761 | $116,318 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,595 | $499,689 | 0.01% |
| Virtu Financial LLC | 22,639 | $140 | 0.01% |
| MML INVESTORS SERVICES, LLC | 73,376 | $455 | 0.00% |
| Point72 (DIFC) Ltd | 4,927 | $30,547 | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 813 | $5,041 | 0.00% |
| Schonfeld Strategic Advisors LLC | 21,452 | $133,002 | 0.00% |
| Nuveen Asset Management, LLC | 382,188 | $2,369,566 | 0.00% |